Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
URB447
Cat. No.:
OB0425LY-078
Appearance:
Solid
Purity:
≥99.5%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
URB447 is a CB1 cannabinoid antagonist. It reduces food intake and weight gain in mice without disturbing the brain or antagonizing central responses.
Synonyms:
1132922-57-6; [4-Amino-1-[(4-chlorophenyl)methyl]-2-methyl-5-phenylpyrrol-3-yl]-phenylmethanone; {4-Amino-1-[(4-chlorophenyl)methyl]-2-methyl-5-phenyl-1H-pyrrol-3-yl}(phenyl)methanone
CAS No.:
1132922-57-6
Compound CID:
25195055
Formula:
C25H21ClN2O
Formula Weight:
400.9
Specification
Target:
Cannabinoid receptor
Pathway:
GPCR/G protein; Neuronal signaling
Storage:
Storage at -20°C.
Applications:
URB447 can be used in obesity research e.g. to construct animal models.
